Gastrointestinal effects and dehydration: Zepbound commonly causes gastrointestinal adverse effects, including nausea, vomiting, and diarrhea, particularly during treatment initiation and dose escalation
Immune-modulating peptides may influence angiogenesis, fibrosis, or tumor biology, requiring indication-specific risk assessment
BAF53 forms distinct nuclear complexes and functions as a critical c-Myc-interacting nuclear cofactor for oncogenic transformation
Starting mid-2026, Medicare will cover injectable weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound for eligible individuals with severe obesity or related health conditions, at a cost of $245 per month to Medicare and a maximum $50 monthly copay for recipients
Different macronutrients activate distinct signalling pathways, with protein and certain types of dietary fibre being particularly effective stimulators
This remains a hypothesis